Statin therapy in multimorbid older patients with polypharmacy- a cross-sectional analysis of the Swiss OPERAM trial population

BACKGROUND: Statin therapy in multimorbid older individuals with polypharmacy is controversial, particularly in primary prevention of cardiovascular disease. Thereby, physicians must weigh potential benefits against potential side effects, drug-drug interactions, and limited life expectancy. AIM: To...

Descripción completa

Detalles Bibliográficos
Autores principales: Adam, Luise, Baretella, Oliver, Feller, Martin, Blum, Manuel Raphael, Papazoglou, Dimitrios David, Boland, Benoit, Aujesky, Drahomir, Baggio, Stéphanie, Rodondi, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551156/
https://www.ncbi.nlm.nih.gov/pubmed/37808883
http://dx.doi.org/10.3389/fcvm.2023.1236547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551156/
https://www.ncbi.nlm.nih.gov/pubmed/37808883
http://dx.doi.org/10.3389/fcvm.2023.1236547

Ejemplares similares